Share

Updates matching "Access to Biomarker Testing"

January 9, 2023
Washington

OLYMPIA, WA. – As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges state lawmakers to prioritize legislation that ensures biomarker testing is appropriately covered by more insurance plans, including Apple Health, which will ease the burden of cancer on Washington residents.

January 9, 2023
New York

The following originally appeared in the Albany Times Union on January 9, 2023. In 2022, an estimated 118,830 New Yorkers received the three lifechanging words “you have cancer” and around 32,230 died from the disease. Innovation in early detection and cancer care are changing how we detect

January 3, 2023
Kentucky

Kentucky Can and Must Do Better When it Comes to Reducing the Cancer Burden

January 3, 2023
Ohio

As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

January 3, 2023
Kentucky

Kentucky Can and Must Do Better When it Comes to Reducing the Cancer Burden

December 18, 2022
Ohio

As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.

December 12, 2022
New York

ALBANY , NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany. WHEN : Santa Clause and

December 6, 2022
New York

The following was originally published in the Empire Report on December 6, 2022. With over 118,000 New Yorkers forced to hear the dreaded three words “you have cancer” every year, it’s easy to forget the incredible strides in early detection and treatment we’ve made in the last 20

June 21, 2022
California

The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.